検索結果

.：J. Ocul. Pharmacol. 1993; 9(4): 373-384. (PMID: 7906296) 3) Tissié, G. et al.：J. Ocul. Pharmacol. Ther. 2002; 18(1): 65-73. (PMID: 11858616) 4) 山本 哲也ほか：日本眼科学会雑誌. 2007; 111(6): 463-472. 5) 川瀬 和秀ほか：日本...

Presence of Products | Overseas Activities | SENJU Pharmaceutical

nd Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmaceticals Factory BRONUCK Oman Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmaceticals Factory BR...

R&D Pipeline | Research & Development | SENJU Pharmaceutica

PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeLaunched（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye

千寿製薬について | 千寿製薬株式会社

CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy

千寿製薬株式会社

apan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treat...